Navigation Links
Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
Date:9/19/2008

of annual physicals for children before the school year.

Seasonal Influenza

The majority of individuals with influenza recover in less than two weeks; however, some may develop life-threatening complications such as pneumonia. In addition, influenza exacerbates the symptoms of chronic health conditions such as diabetes, asthma and congestive heart failure. The most severe disease occurs in infants and young children and adults older than 65 years of age. The CDC reports that 15 to 60 million people in the U.S. contract influenza each year leading to over 200,000 hospitalizations and 36,000 deaths. The Advisory Committee on Immunization Practices ("ACIP"), which has been expanding recommendations for seasonal influenza vaccination for the last several years, currently recommends seasonal influenza vaccination for children 6 months through 18 years of age, pregnant women, adults over 50 years of age, and individuals of any age with chronic health conditions or who are at high risk of influenza disease. Based on the expanding recommendation of vaccination to new age groups, the growing worldwide population to be vaccinated, and the need of an improved influenza vaccine for the elderly, global market projections of seasonal influenza are estimated to increase from $2.8 billion in 2007 to $6.5 billion by 2013.

About Novavax

Novavax, Inc. is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new, and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.

Forward Looking Statement

Statements herein relating to future development result
'/>"/>

SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
2. Novavax Announces Closing of $18 Million Registered Direct Offering
3. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
4. Novavax to Join Russell 3000 Index
5. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
6. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference
7. Novavax CEO to Present at ACUMENBioFins 5th Annual Global Healthcare Conference
8. Novavax Reports First Quarter 2008 Financial Results
9. Novavax Announces Release Date of 2008 First Quarter Financial Results and Investor Conference Call
10. Novavax Opens Its First U.S. Vaccine Plant
11. Novavax CEO to Present at the World Vaccine Congress 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... (PRWEB) June 17, 2013 As a leader ... committed to finding a cure all for acne, rosacea, and ... AARS (Acne and Rosacea Society) has dedicated ... and helping to educate the public on treatment options. Probiotic ... by announcing their daily news updates via social networks and ...
(Date:6/17/2013)... (PRWEB) June 17, 2013 With the huge ... launch of the Chief Medical Officer Summit for Emerging Life ... will take place in San Francisco on November 4-5, 2013 ... the first time, West Coast Chief Medical Officers at biotechs ... Elizabeth Stoner, Managing Director of MPM Capital. Valerie Bowling, Executive ...
(Date:6/17/2013)... , June 17, 2013  Minimally Invasive Devices, ... additional $2.5 million from Radius Ventures, topping off ... Series B originally raised $9 million in a ... existing investor, Charter Life Sciences. ... first and only product that actually maintains a ...
(Date:6/17/2013)... Spirax Sarco has embraced the digital age ... Readers can now subscribe to a digital version available as ... fully downloadable to an iPad or iPhone so plant managers, ... read all of its content at home or on the ... the current digital edition with additional interactive features to enhance ...
Breaking Biology Technology:Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2Chief Medical Officer Summit for Biotechs Goes West 2Chief Medical Officer Summit for Biotechs Goes West 3Minimally Invasive Devices Adds $2.5 Million to its Series B 2Spirax Sarco Launches Steam News Magazine for iPad and iPhone 2
... York, September 25 XTL,Biopharmaceuticals Ltd. (NASDAQ: XTLB ... General Meeting ("AGM") and Extraordinary General Meeting,("EGM") was postponed ... due to the absence of a quorum. The postponed ... 3, Kiryat Weizmann Science Park,Rehovot, Israel 76100 at 4:00 ...
... SeqWright, Inc., an international,leader in the field of ... Biosystems (ABI) to purchase ABI,s next generation,SOLiD(TM) genetic ... offer commercial access to the latest in Sequencing,Technology. ... and ABI that grows stronger with time. ...
... ,Monsanto Company (NYSE: MON ) and Evogene ... nitrogen use efficiency in corn, soybeans,canola and cotton. ... number of genes discovered by Evogene that help ... will work to evaluate the use,of those genes ...
Cached Biology Technology:XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007 2SeqWright Unveils ABI SOLiD(TM) Next Generation Genetic Analysis System 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 3
(Date:6/17/2013)... BOSTON , June 17, 2013 ... prolific, the need to secure them grows exponentially, ... the latest report from Heavy Reading Insider ... from Heavy Reading ( www.heavyreading.com ). ... Smartphones examines the market for biometric authentication on ...
(Date:6/17/2013)... Kansas State University research associate has received a prestigious ... to prevent the spread of malaria. , Bart Bryant, ... of Health,s National Research Service Award Individual Postdoctoral Fellowship, ... seventh Kansas State University researcher to receive the award ... hold such an award. , Bryant, a university doctoral ...
(Date:6/17/2013)... declining worldwide and a major cause is a deadly ... two-year study shows they can also die from this ... carrier host that just spreads the disease. , When ... conditions, they found at least one strain of this ... a chytrid fungus, can be fatal to year-old juveniles. ...
Breaking Biology News(10 mins):Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 2Biometric Authentication Provides Better Mobile Device Security, Heavy Reading Finds 3NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Bullfrogs may help spread deadly amphibian fungus, but also die from it 2
... epidemiological model of the spread of the mosquito-borne West Nile ... where 81.6 percent of human cases of the disease would ... turned out to be 39 times higher than in low-risk ... in those predictions is now open-source and is being applied ...
... PITTSBURGHThe transport system inside living cells is a well-oiled machine ... cargo around the cell. These molecular motors are responsible for ... always on the go. They can put themselves into "energy ... control what gets moved around the cell, and when. ...
... may not sound very glamorous, a new method of ... news for both confined animal operations and environmental groups, ... The method uses gas-permeable membrane technology that tests have ... in liquid manure in 20 days. The removed ammonium ...
Cached Biology News:Software predicted risk in California West Nile virus epidemic 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 2Carnegie Mellon scientists discover how molecular motors go into 'energy save mode' 3New technology could capture ammonia from liquid manure 2New technology could capture ammonia from liquid manure 3
... Mouse monoclonal [HDAC8-48] to HDAC8 ... by several mechanisms such as DNA ... translational modifications of histones, which include ... epsilon-amino groups of lysine residues present ...
... Mouse polyclonal antibody raised ... Immunogen: ... 156 a.a) partial recombinant protein ... Accession Number: NM_021977 ...
...
...
Biology Products: